Cognitive Longevity

Making brain health screening as routine and accessible as any other essential health check

ESYA FOR Neurodegenerative diseases

We combine patented intracellular multi-omics analytics using DNA Nanoprobes, Proteomics, and AI to uncover novel pathways for Neurodegenerative diseases

We combine patented intracellular analytics using DNA nanoprobes with AI to diagnose neurodegenerative diseases before symptoms manifest.

white image of

We use patented DNA nanotechnology

A paradigm shift in understanding how Alzheimer’s and Parkinson’s diseases manifests opens up a whole new way of diagnosing, treating and managing the disease.

Advanced Probes by Esya

Our patented probes are designed to capture sub-cellular properties with exceptional precision, delivering deep insights into cellular functions and processes.

Multi-Omics Data Analysis Platform

Our platform leverages multi-omics data through advanced AI models, coupled with bioinformatics analysis, providing robust insights for studies.
colored image of

Voltair

DNA-based sensor for absolute membrane potential of cell and organelle membranes. Relevant to various neurological diseases, hypokalemia, or hyperkalemia

ca illustration drawing

CalipHluor

DNA-based, ratiometric combination reporter of pH and Ca2+. Relevant to Alzheimer’s disease, Pakinson's disease and Kufor Rakeb syndrome.

ci illustration drawing

Clensor

pH-independent, ratiometric Cl- sensor, single colour, multiplexing enabled. Relevant to Lysosomal storage disorders and Niemann Pick.

close up image

NOckout

DNA-based ratiometric NO sensitive probes. Relevant to cancer, autoimmune disease, sepsis and trauma, and vascular disease.

two medical scientists
Our Assays

Accelerate Drug Development

Our ratio-metric assays and multiplexed proteomic panels are exceptional in their ability to quantify the key chemicals within endosomes (early, recycling, and late), lysosomes, and the golgi. They can be used to complement drug discovery and patient stratification, as well as assess drug efficacy as an end point in clinical trials for lysosomal storage disorders and numerous neurocognitive impairments.

Passion is what drives us

Esya's vision is to set a new global standard in brain health by integrating biomarker analysis and deep learning to drive transformative drug discovery, delivering insights that refine precision medicine

Get in touch to discuss how our probes can help you with your work .

Let's discuss now
Get In Touch With Us